PureFunds ETFx HealthTech ETF
IMED
IMED was delisted on the 6th of September, 2017.
2 hedge funds and large institutions have $896K invested in PureFunds ETFx HealthTech ETF in 2017 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
2% less capital invested
Capital invested by funds: $915K → $896K (-$19K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$1.97K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
-$117K |
IMED Hedge Fund Activity: Q1 2017 in Review
2 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in PureFunds ETFx HealthTech ETF (IMED) for Q1 2017, worth a combined $896K — down 2.1% from $915K a quarter earlier.
Fund positioning in IMED was balanced in Q1 2017: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, adding an estimated $1.97K. The largest seller was Virtu KCG Holdings, cutting an estimated $117K.
- 2 institutional investors held PureFunds ETFx HealthTech ETF (IMED) as of Q1 2017, unchanged from Q4 2016.
- Funds reported $896K of PureFunds ETFx HealthTech ETF stock for Q1 2017, down 2.1% quarter-over-quarter.
- 0 funds opened new PureFunds ETFx HealthTech ETF positions in Q1 2017 and 0 closed out.
- The largest PureFunds ETFx HealthTech ETF buyer in Q1 2017 was UBS Group, an estimated $1.97K added.
- The largest PureFunds ETFx HealthTech ETF seller in Q1 2017 was Virtu KCG Holdings, an estimated $117K sold.
Based on aggregated 13F filings for Q1 2017.